PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Independence Blue CrossCommercial · Coverage · Medical Policy · ENT (Ear, Nose & Throat), Pulmonology, Oncology +1 moreMedium impact

08.02.48, Papzimeos (zopapogene imadenovec-drba)

Effective date
Aug 3, 2026
Identified
Aug 4, 2026

Summary

Independence Blue Cross has published a new medical policy (08.02.48) effective 08/03/2026 covering Papzimeos (zopapogene imadenovec-drba) for treatment of recurrent respiratory papillomatosis (RRP) in adults. Coverage is limited to a single lifetime treatment course of four injections over 12 weeks when specific clinical criteria are met, including confirmed HPV 6/11 diagnosis, prior surgical intervention, and prescriber attestation of surgical debulking protocols. Billing teams must implement prior authorization requirements and ensure claims are submitted only when all medical necessity criteria are documented.

Get alerts when payers change rules like this one

We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.

Get Independence Blue Cross alertsPolicy Monitoring is free. No card required.

What to do

Action · 8 steps
01By 08/03/2026: Billing team must implement the following.
02Add HCPCS code J3404 to billing system with mandatory prior authorization flag for all claims.
03Configure system to reject claims exceeding four total doses per 12-week period per patient lifetime.
04Require providers to submit documentation confirming all medical necessity criteria are met before claim submission, including histology/biopsy confirming HPV 6 or 11, evidence of prior surgical/systemic interventions, and prescriber attestation of surgical debulking plans.
05Train providers and front desk staff that J3404 requires prior authorization and supporting clinical documentation.
06Update encounter forms and billing templates to include checklist for RRP diagnosis confirmation, HPV serotype documentation, and intervention history.
07Claims submitted without complete medical necessity documentation or exceeding the one-time lifetime course limit will be denied.
08Coordinate with otolaryngology, pulmonology, thoracic surgery, and oncology departments regarding new coverage criteria.

Codes mentioned

J3404B97.7D14.1J38.7

Original notice

08.02.48, Papzimeos (zopapogene imadenovec-drba)
medpolicy.ibx.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account